Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. Aims: To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. Method: A search was made of the Medline database (1966–2002) for key articles, supplemented by cross-referencing. Results: During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17–78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. Conclusions: Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatric patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001 · cited 1×
“It has been estimated that in humans as much as 25% of trabecular bone and 3% of cortical bone are resorbed and replaced each year (Parfitt, 1994).”
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia
Rao, M. L., Gross, G., Strebel, B., Halaris, A., Huber, G., Bräunig, P., & Marler, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91147-9 · Cited by 154 · cited 1×
“In drug-free patients with acute or chronic major psychiatric disorders prolactin secretory patterns measured throughout the day are no different from those in normal controls (Linkowski et al, 1989; Rao et al, 1994).”
Cited by
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Self-citationMeaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
“that prolactin levels in antipsychotic-naive patients with schizophrenia or bipolar spectrum disorders appear to be comparable with those observed in the general population.(13) Elevated prolactin levels in patients receiving antipsychotic medications are therefore likely to be attributable to the medication rather th…”
ResultCohrs, S., Röher, C., Jordan, W., Meier, A., Huether, G., Wuttke, W., Rüther, E., & Rodenbeck, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0279-x · Cited by 141
Risk of hip/femur fractures in patients using antipsychotics
Hugenholtz, G. W. K., Heerdink, E. R., van Staa, T. P., Nolen, W. A., & Egberts, A. C. G. (2005) · Bone · doi:10.1016/j.bone.2005.07.005 · Cited by 77
“Which is probably caused by the effect of antipsychotics on decreasing bone mineralization, leading to weaker bones [3,5,12,21,25,39].”
Background
Metadata
- Authors
- Wieck, A., & Haddad, P. M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2003-03
- Volume
- 182
- Issue
- 3
- Pages
- 199-204
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1973003196
- Cited by
- 167
- References
- 3
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review. https://app.cochat.ai/papers/10.1192/bjp.182.3.199
- The paper
- Wieck, A., & Haddad, P. M. (2003). Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review. British Journal of Psychiatry. https://doi.org/10.1192/bjp.182.3.199
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.